Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
Clinical trial NCT00161785 · COMPLETED
Trial details
- NCT number
- NCT00161785
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.